- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03704272
Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral (SunBrite)
Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral (SunBrite)
Study Overview
Status
Intervention / Treatment
Detailed Description
SunBrite is a novel, evidence-based intervention for non-accidental trauma (NAT) that has not, as yet, been implemented in any health care setting. Current programs targeting NAT vary widely, and there is insufficient research to conclude that these efforts have reduced re-admission rates(12,13). EDs primarily screen for risk factors associated with child abuse, focusing on their role in reporting and developing forensic evidence for investigations but not on risk reduction. While such efforts as embedding child protection teams in trauma programs are a starting point, much more needs to be done to develop a standard of care and empirically demonstrate efforts that reduce the risk of subsequent injury.
The overlap between non-accidental trauma (NAT) and inadequate caregiver supervision provides an opportunity to identify and intervene during earlier health care visits for children at risk for severe or fatal injury. Because head injuries account for over 80% of all suspected non-accidental injuries and over 90% of fatalities in the pediatric population, this intervention specifically targets all children ages 0-2 years who present in the Phoenix Children's Hospital (PCH) ED with a diagnosed head injury of any kind not resulting from a motor vehicle collision (MVC). These injuries include, but ae not limited to, abrasions, contusions, hematoma, ischemia, fractures, swelling or bruising. In this way, SunBrite expands the scope of detection for NAT to include injuries resulting from supervisory neglect.
PCH will implement the SunBrite pilot protocol in collaboration with key community partners who will be extensively involved in project design, implementation, and evaluation. In preparation for study recruitment, PCH and its partners will formalize the SunBrite process, create a curriculum, draft training tools to support the fidelity of SunBrite, finalize study materials (e.g., worksheets, data collection forms, interview scripts, consent documentation, and logic model), and conduct professional training. Once development is complete, pediatric patient families will be enrolled into the pilot program.
SunBrite study will utilize a simple, randomized, prospective study design, with 221 eligible pilot study participants randomized upon triage to one of two study arms: the control arm (73 families) or the treatment arm (148 families). Families in the control group will receive treatment as usual (TAU), which includes reporting to child welfare agencies when appropriate. In the treatment group, the patient/family will receive the SunBrite protocol, whose components include a screening, a brief intervention based in motivational interviewing (MI) techniques, and referral to treatment. All abuse and neglect, no matter the study arm, will be reported in accordance with hospital policy, federal and state laws.
All self-identified primary caregivers (legal guardians or parents) of children ages 0-2 who present in the PCH ED with a diagnosed intracranial injury will be automatically screened for eligibility. Caregivers will be initially screened by ED clinicians (e.g., physicians, nurse-practitioners) for eligibility based on age, injury (head), and method of injury (MOI) (non-MVC) using a standard clinical interview currently in place. All caregivers who screen positive based on these three criteria will then be deemed eligible for SunBrite. A trauma social worker will be notified by the ED that they have an eligible patient for consult. The social worker will meet the family and briefly describe the study and their eligibility. If they are willing to participate, the social worker will then obtain informed consent. All patient families will be fully consented in person in English or Spanish.
The screening, brief intervention, and referral to treatment will occur in the ED in the form of an abbreviated social work consultation prior to discharge. A social worker will complete an assessment for supervisory and household risks and then complete an injury risk worksheet to be used in the brief intervention. The social worker will engage caregivers in a 20- to 30-minute motivational interview (i.e., social work consult) using parent-coaching techniques for medical settings(12). In-person coaching facilitates active practice of these skills, supports further development of desired behaviors, and promotes long-term, sustainable risk mitigation.
The referral-to-treatment component of SunBrite identifies risks that may require further professional intervention, such as a history of trauma, mental illness, or substance abuse. For risks that warrant longer-term treatment, social workers will make referrals to external agencies and professionals for psychiatric evaluation, medication management, medically-assisted treatment (MAT), cognitive-behavioral therapy, and PTSD treatment.
Data from all participants, regardless of randomization, will be collected from patient health records. This will include patient demographics, injury characteristics, labs, imaging, consults, diagnoses, treatments, complications, and discharge notes. Patients will be followed for up to 12 months to assess study outcomes. The primary outcomes for this study are rates re-hospitalization (including frequency of hospitalization and length of stay) and return ED visits for any ICD-10 code. Secondary outcomes include complications from the indexed traumatic injury, other illnesses and conditions unrelated to trauma, and cost savings from reduced ED return visits and admissions. Based on PCH admissions data, we expect that 50% of eligible patients will return to the ED with an injury within one year of discharge. In addition to tracking all patients for 12 months post-discharge for any diagnosis at PCH, we will match our participants to the statewide database housed at the Arizona State University (ASU) Center for Health Information Research.
Quantitatively, we hypothesize that the proportion of patients measured on the primary outcome (return to ED) for the experimental group will be statistically smaller than the proportion in the control group under the following assumptions of a superiority design: 1) the percentage of patients that we expect to return to the ED is approximately 50% for the control group within one year of discharge to home and 25% for the experimental group; 2) the risk of type I error is alpha=.025; 3) power=.80. These parameters require a total sample size of 134 with a sample size of 67 for each group. However, we are planning to randomize in an unequal allocation of 2:1 to the experimental arm and oversample by 10%, bringing the total sample size up to 221 (148 in the experimental arm and 73 in the control arm). This design has an advantage in early phase trials, allowing investigators to explore treatment dimensions and optimize treatment utility.
We will also employ qualitative methods to provide rich feedback to enhance the implementation process and ensure project fidelity (e.g., identifying barriers and strategies to sustainability and wider dissemination). A formative evaluation of SunBrite will follow a plan, do, review, revise cycle of performance management that addresses the following intervention components: screening, staffing, brief intervention fidelity, referral, data collection, and reporting. . Quarterly advisory board meetings with community partners throughout the pilot program will provide an opportunity to update stakeholders on the pilot and receive feedback on implementation. Interviews with key stakeholders occurring at the start of the pilot, during program recruitment, and at the end of the recruitment process will provide important feedback to keep the pilot on track and achieve program goals. Voluntary interviews will assess experience with implementation and acceptability of SunBrite as implemented. Significantly, a research plan will be developed to validate SunBrite in a multi-site randomized trial.
To prepare for SunBrite information dissemination statewide, PCH will facilitate ongoing development of a formalized screening tool for use in EDs and manualize the SunBrite brief intervention and referral system. We will also design a dissemination plan (including funding) for SunBrite to incorporate a telemedicine option for the brief intervention. We will also disseminate findings from the pilot nationally through speaking engagements, conferences, posters, and published papers. In coordination with our community partners, we will develop a plan to sustain SunBrite in the PCH ED and to promote dissemination to other trauma centers.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lois Sayrs, PhD
- Phone Number: 602-933-0148
- Email: lsayrs@phoenixchildrens.com
Study Contact Backup
- Name: Jodie Greenberg, MA
- Phone Number: 602-933-4045
- Email: jgreenberg@phoenixchildrens.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Pediatric patients under the age of 2 presenting to the ED with intracranial trauma not resulting from a motor vehicle accident.
- Children admitted overnight for observation may be included in the study. Because of the age of the child, most children are held overnight or longer.
Exclusion Criteria
- Children with a head injury associated with a motor vehicle collision.
- Children whose guardian does not present in the ED with the patient at the time of admission.
- Children with developmental disabilities or autism.
- Medically fragile children, children with chronic illness, or children diagnosed with failure to thrive.
- Caregivers/guardians who do not speak English or Spanish
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Families in the control group will receive treatment as usual, which includes reporting to child welfare agencies when appropriate.
|
|
Experimental: Treatment
SunBrite
|
SunBrite is a family-empowered injury risk mitigation intervention with 3 core components: screening for the risk of supervisory neglect associated with traumatic injury in very young children; a brief behavioral intervention using motivational interviewing designed to provide feedback to the caregiver on supervisory risk and traumatic injury; and a referral to treatment for ongoing risks such as substance abuse, trauma or mental illness, requiring specific clinical interventions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Return visits to emergency department for any ICD-10 code
Time Frame: 12 months post enrollment
|
Measured by the number of admissions to the ED as recorded in the patient's medical chart.
|
12 months post enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complications from traumatic head injury
Time Frame: 12 months post enrollment
|
Any complications resulting from intracranial injury that child presents with in ED.
|
12 months post enrollment
|
All illnesses and conditions of participant, including those unrelated to traumatic head injury
Time Frame: 12 months post enrollment
|
Assessed via review of illnesses and conditions as recorded in the patient's medical chart.
|
12 months post enrollment
|
Cost savings
Time Frame: 12 months post enrollment
|
Savings resulting from reduced ED visits and readmissions to hospital.
|
12 months post enrollment
|
Frequency of re-hospitalization
Time Frame: 12 months post enrollment
|
Measured by number of hospital admissions as recorded in the patient's medical chart.
|
12 months post enrollment
|
Hospital lengths of stay
Time Frame: 12 months post enrollment
|
Measured in days as recorded in the patient's medical chart.
|
12 months post enrollment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David M Notrica, MD, Phoenix Children's Hospital
Publications and helpful links
General Publications
- Louwers EC, Korfage IJ, Affourtit MJ, Scheewe DJ, van de Merwe MH, Vooijs-Moulaert FA, Woltering CM, Jongejan MH, Ruige M, Moll HA, De Koning HJ. Detection of child abuse in emergency departments: a multi-centre study. Arch Dis Child. 2011 May;96(5):422-5. doi: 10.1136/adc.2010.202358. Epub 2011 Jan 30.
- King WK, Kiesel EL, Simon HK. Child abuse fatalities: are we missing opportunities for intervention? Pediatr Emerg Care. 2006 Apr;22(4):211-4. doi: 10.1097/01.pec.0000208180.94166.dd.
- Bray JW, Del Boca FK, McRee BG, Hayashi SW, Babor TF. Screening, Brief Intervention and Referral to Treatment (SBIRT): rationale, program overview and cross-site evaluation. Addiction. 2017 Feb;112 Suppl 2:3-11. doi: 10.1111/add.13676.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18-151
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neglect, Child
-
Yeditepe UniversityRecruitingEducational Program's Impact on Nursing Students' Knowledge and Awareness of Child Abuse and NeglectChild Abuse | Child NeglectTurkey
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedChild Abuse | Child NeglectUnited States
-
Oral Health Centre of Expertise in Western NorwayOral Health Center of Expertise Rogaland, Norway; Childrens advocacy center... and other collaboratorsRecruitingChild Abuse | Child Neglect | Child MaltreatmentNorway
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruiting
-
Institute of Psychiatry, LondonBanaras Hindu University; Tribhuvan University, NepalCompletedChild Abuse | Child Neglect | VictimizationIndia, Nepal
-
University of OklahomaNational Institute of Mental Health (NIMH); Centers for Disease Control and... and other collaboratorsCompleted
-
Milton S. Hershey Medical CenterRecruitingChild Abuse | Child Neglect | Child MaltreatmentUnited States
-
University of OklahomaActive, not recruitingChild Abuse | Parenting | Child Development | Child NeglectUnited States
-
Boston Medical CenterCenter for the Study of Social PolicyCompletedChild Abuse | Parenting | Child Development | Child Rearing | Child NeglectUnited States
-
University of New MexicoActive, not recruitingChild Abuse | Parenting | Child Behavior | Child Development | Delinquency | Criminal Behavior | Child NeglectUnited States